abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

This page is not available in español and is being displayed in English

Artículo

USA: Top drug distributors settle opioid lawsuit for $260 million

"Companies Reach $260 Million Deal to Settle Opioids Lawsuit", 21 Oct 2019

The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle a lawsuit related to the opioid crisis just as the first federal trial over the crisis was due to begin Monday...

The settlement means the closely watched trial will not move forward now, but it does not resolve more than 2,600 other lawsuits across the country seeking to hold the drug industry accountable for an opioid crisis...

The settlement ends only the suits brought by the Ohio counties of Cuyahoga and Summit...

After the new settlements and previous ones with five other drugmakers, the only defendant left in the trial that had been scheduled for Monday is the pharmacy chain Walgreens. The new plan is for Walgreens and other pharmacies to go to trial within six months if they don’t reach settlements first.

Story Timeline